Dianthus Therapeutics, Inc. ( DNTH) - Key Metrics
DNTH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.90 | -$0.87 | -$0.88 |
| 2026Q1 | $0.01 | -$0.85 | -$0.60 | -$0.60 |
| 2025Q4 | $0.01 | $2.59 | -$1.24 | -$1.25 |
| 2025Q3 | $0.01 | -$0.97 | -$0.81 | -$0.81 |
| 2025Q2 | $0.01 | -$0.88 | -$0.67 | -$0.67 |
DNTH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -27.08 |
| 2026Q1 | 0% | -24.68 |
| 2025Q4 | 0% | 3.98 |
| 2025Q3 | 0% | -10.14 |
| 2025Q2 | 0% | -5.29 |
DNTH
Price: $113.70
52 week price:
Earnings Per Share: -4.39 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 6.1 billion